Steroid hormone receptors in cancer development: A target for cancer therapeutics (Q37798330)

23 August 2017

title

Steroid hormone receptors in cancer development: a target for cancer therapeutics (English)

1 reference

23 August 2017

Steroid hormone receptors in cancer development: A target for cancer therapeutics (English)

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

28 July 2024

author name string

Nihal Ahmad

1

1 reference

23 August 2017

Raj Kumar

2

1 reference

23 August 2017

language of work or name

English

0 references

publication date

1 January 2011

1 reference

full work available at URL

23 August 2017

https://api.elsevier.com/content/article/PII:S0304383510004313?httpAccept=text/plain

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

https://api.elsevier.com/content/article/PII:S0304383510004313?httpAccept=text/xml

28 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

28 July 2024

1 reference

23 August 2017

volume

300

1 reference

23 August 2017

issue

1

1 reference

23 August 2017

page(s)

1-9

1 reference

Role of progesterone in endometrial cancer

23 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Estrogen regulation of apoptosis: how can one hormone stimulate and inhibit?

28 July 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Endocrine therapy--current benefits and limitations

28 July 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Endocrine treatment in prostate cancer

28 July 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Steroid hormones and cancer: (III) observations from human subjects

28 July 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Androgen regulation of gene expression

28 July 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Modulation of steroid hormone receptor activity

28 July 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Glucocorticoids: extensive physiological actions modulated through multiple mechanisms of gene regulation.

28 July 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Progesterone action in human tissues: regulation by progesterone receptor (PR) isoform expression, nuclear positioning and coregulator expression

28 July 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Mechanisms underlying the control of progesterone receptor transcriptional activity by SUMOylation

28 July 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Functional potentiation of leptin-signal transducer and activator of transcription 3 signaling by the androgen receptor

28 July 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Principles for modulation of the nuclear receptor superfamily

28 July 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

On the mechanism of estrogen action

28 July 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Integration of the extranuclear and nuclear actions of estrogen

28 July 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Transcriptional control of energy homeostasis by the estrogen-related receptors

28 July 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Estrogen targets genes involved in protein processing, calcium homeostasis, and Wnt signaling in the mouse uterus independent of estrogen receptor-alpha and -beta

28 July 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Structural overview of the nuclear receptor superfamily: insights into physiology and therapeutics

28 July 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

The mineralocorticoid receptor and its coregulators.

28 July 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Nuclear receptor coregulators in cancer biology

28 July 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Building transcriptional regulatory complexes: signals and surfaces

28 July 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases

28 July 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family

28 July 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Multi-modulation of nuclear receptor coactivators through posttranslational modifications

28 July 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Cracking the coregulator codes

28 July 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Nuclear receptor coregulators: judges, juries, and executioners of cellular regulation

28 July 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Mechanisms of androgen receptor signalling via steroid receptor coactivator-1 in prostate.

28 July 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Overview of the structural basis for transcription regulation by nuclear hormone receptors

28 July 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Transactivation functions of the N-terminal domains of nuclear hormone receptors: protein folding and coactivator interactions

28 July 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

The structure of the nuclear hormone receptors

28 July 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Structure of the intact PPAR-gamma-RXR- nuclear receptor complex on DNA

28 July 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Site-specific phosphorylation induces functionally active conformation in the intrinsically disordered N-terminal activation function (AF1) domain of the glucocorticoid receptor

28 July 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Interdomain signaling in a two-domain fragment of the human glucocorticoid receptor

28 July 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Mechanisms of Corticosteroid Resistance in Rheumatoid Arthritis

28 July 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Recent insights into the mechanism of glucocorticosteroid-induced apoptosis

28 July 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Quantitative analysis for human glucocorticoid receptor alpha/beta mRNA in IBD.

28 July 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Expression of glucocorticoid receptors alpha and beta in steroid sensitive and steroid insensitive interstitial lung diseases.

28 July 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Glucocorticoids reduce pro-inflammatory cytokines and tissue factor in vitro and improve function of transplanted human islets in vivo

28 July 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Molecular mechanisms of glucocorticoid action and resistance

28 July 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Mechanisms of glucocorticoid-mediated apoptosis in hematological malignancies

28 July 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Glucocorticoid signalling--multiple variations of a common theme

28 July 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Cross talk of signaling pathways in the regulation of the glucocorticoid receptor function

28 July 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Modulation of glucocorticoid receptor function via phosphorylation.

28 July 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Demonstration of the mineralocorticoid hormone receptor and action in human leukemic cell lines

28 July 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Assessing women at high risk of breast cancer: a review of risk assessment models

28 July 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Estrogens, regulation of p53 and breast cancer risk: a balancing act.

28 July 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Dietary patterns and breast cancer risk: a systematic review and meta-analysis

28 July 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Factors to consider in the association between soy isoflavone intake and breast cancer risk

28 July 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Primary prevention of breast cancer by hormone-induced differentiation.

28 July 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Estrogen receptors: how do they signal and what are their targets

28 July 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Therapeutic potential of selective estrogen receptor modulators

28 July 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Genetic susceptibility to breast cancer

28 July 2024

51

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Emergence of rationally designed therapeutic strategies for breast cancer targeting DNA repair mechanisms

28 July 2024

53

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

BRCA1, BRCA2, BRCA3 ... a myriad of breast cancer genes

28 July 2024

54

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Oestrogen receptor beta (ERbeta) polymorphism and its influence on breast cancer risk

28 July 2024

55

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Estrogen receptor polymorphisms: significance to human physiology, disease and therapy

28 July 2024

56

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Synergistic effects of polymorphisms in DNA repair genes and endogenous estrogen exposure on female breast cancer risk.

28 July 2024

57

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Lifestyle and breast cancer risk: the way forward?

28 July 2024

58

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Associations between lifestyle factors and quality of life among older long-term breast, prostate, and colorectal cancer survivors

28 July 2024

59

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Effects of estrogen on breast cancer development: Role of estrogen receptor independent mechanisms

28 July 2024

61

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Estrogen action: a historic perspective on the implications of considering alternative approaches

28 July 2024

62

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Prostate cancer: the new landscape

28 July 2024

64

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Multifocal prostate cancer: biologic, prognostic, and therapeutic implications

28 July 2024

65

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Molecular imaging of cancer: MR spectroscopy and beyond

28 July 2024

66

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Do African American men have lower survival from prostate cancer compared with White men? A meta-analysis

28 July 2024

67

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Molecular mechanisms involving prostate cancer racial disparity

28 July 2024

68

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Gene expression profiling in the developing prostate

28 July 2024

69

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Molecular regulation of androgen action in prostate cancer

28 July 2024

70

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Prostate cancer: a review of therapeutic strategies

28 July 2024

71

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Oncogenic activation of androgen receptor

28 July 2024

72

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Androgen receptor coregulators and their involvement in the development and progression of prostate cancer.

28 July 2024

73

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Selective androgen receptor modulators as function promoting therapies

28 July 2024

74

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

The role of androgen receptor mutations in prostate cancer progression.

28 July 2024

75

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Analysis of the molecular networks in androgen dependent and independent prostate cancer revealed fragile and robust subsystems

28 July 2024

76

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

New strategies for the medical treatment of prostate cancer

28 July 2024

77

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Androgen receptor-mediated repression of novel target genes

28 July 2024

78

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Hormonal therapy of prostate cancer

28 July 2024

79

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Advances in the diagnosis and treatment of prostate cancer

28 July 2024

80

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Short alleles of both GGN and CAG repeats at the exon-1 of the androgen receptor gene are associated to increased PSA staining and a higher Gleason score in human prostatic cancer

28 July 2024

82

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Mechanistic relationship between androgen receptor polyglutamine tract truncation and androgen-dependent transcriptional hyperactivity in prostate cancer cells

28 July 2024

83

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Androgen receptor polymorphisms: Association with prostate cancer risk, relapse and overall survival

28 July 2024

84

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Androgen receptor CAG repeat lengths in prostate cancer: correlation with age of onset

28 July 2024

85

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Androgen receptor CAG repeats and prostate cancer

28 July 2024

86

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Ovarian cancer: epidemiology, biology, and prognostic factors

28 July 2024

87

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Estrogen, progesterone and epithelial ovarian cancer

28 July 2024

88

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Borderline ovarian tumors and fertility

28 July 2024

89

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Current understanding of risk factors for ovarian cancer

28 July 2024

90

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Prognosis and hormone receptor status in older and younger patients with advanced-stage papillary serous ovarian carcinoma

28 July 2024

93

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Cancer incidence in a cohort of infertile women

28 July 2024

94

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Hormone replacement therapy and endometrial, ovarian and colorectal cancer.

28 July 2024

95

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Risk factors and risk reduction of breast and ovarian cancer

28 July 2024

96

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

28 July 2024

HRT and cancer risks

97

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Progesterone-dependent regulation of female reproductive activity by two distinct progesterone receptor isoforms.

28 July 2024

98

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Differential expression of progesterone receptor isoforms A and B in the normal ovary, and in benign, borderline, and malignant ovarian tumors

28 July 2024

99

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Reproductive hormone-induced, STAT3-mediated interleukin 6 action in normal and malignant human ovarian surface epithelial cells

28 July 2024

100

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Progesterone induces apoptosis and up-regulation of p53 expression in human ovarian carcinoma cell lines

28 July 2024

101

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

Apoptosis induced by progesterone in human ovarian cancer cell line SNU-840.

28 July 2024

103

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.09.008

28 July 2024

Identifiers

1 reference

23 August 2017

1 reference